Invesco Earnings Preview: Analysts Expect Strong Growth

Analysts anticipate Invesco Ltd. to report a 21.2% increase in EPS for Q1. While facing challenges in revenue due to market trends, the asset manager's recent performance has sparked positive investor sentiment. Investors should closely monitor upcoming earnings reports.

Date: 08-04-2025

AI Rating: 7

**Earnings Outlook**: Invesco Ltd. is poised to report its first-quarter earnings with analysts predicting a non-GAAP profit of $0.40 per share, reflecting a substantial year-over-year growth of 21.2% from $0.33 per share. The anticipated EPS growth indicates improving operational performance and could positively sway market sentiment if achieved.

**Revenue Concerns**: However, the firm's revenue has been hindered as a result of shifting assets under management (AUM) towards lower-fee investment products such as ETFs. This industry trend towards passive investment solutions has pressured fee revenues and could weigh on overall profitability in the longer term.

**Profit Margins**: Despite the pressures, Invesco's successful Q4 highlighted its efforts to streamline operations leading to an increase in adjusted net income by 18.8% year-over-year. This not only suggests a better management of costs but also improved profit margins during that period.

**Long-Term Prospects**: While the company recorded strong inflows and exceeded revenue expectations in the last quarter, there is a need for caution among investors looking into Invesco's long-term referral potential due to existing market challenges. The consensus rating remains a “Hold” from most analysts, indicating a lack of strong conviction to recommend buying the stock at current valuation levels.

**Analyst Ratings**: With 18 analysts covering the stock, opinions are mixed, with the majority suggesting a “Hold” position, reflecting hesitance for significant investment. The stock is currently trading below its mean price target of $19.20, suggesting potential upside but also reflecting market wariness.

Stocks: IVZ XLF